Thomas H. Maren

Q: What Schools Are Affiliated With Thomas H. Maren

Thomas H. Maren is affiliated with the following schools: California Institute of Technology, University of Florida, Princeton University, Stanford University, Johns Hopkins University, University of Florida College of Medicine

Thomas H. Maren's AcademicInfluence.com Rankings

Thomas H. Maren

Chemistry

#1392

World Rank

#2092

Historical Rank

#532

USA Rank

Chemical Engineering

#106

World Rank

#119

Historical Rank

#47

USA Rank

Physical Chemistry

#147

World Rank

#178

Historical Rank

#49

USA Rank

chemistry Degrees

Download Badge

Chemistry

Thomas H. Maren's Degrees

PhD Chemistry Stanford University

Why Is Thomas H. Maren Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Thomas H. Maren was an American professor of medicine at the University of Florida. He was the founding father for the University of Florida College of Medicine, and he invented Trusopt to help people with glaucoma.

(See a Problem?)

Thomas H. Maren's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Carbonic anhydrase: chemistry, physiology, and inhibition. (1967) (1526)
A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. (1960) (310)
Relatons between structure and biological activity of sulfonamides. (1976) (303)
Use of inhibitors in physiological studies of carbonic anhydrase. (1977) (162)
Carbonic anhydrase: General perspective and advances in glaucoma research (1987) (154)
Effect of food restriction on body composition of hereditary obese mice. (1955) (148)
The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. (1983) (147)
The pharmacology of methazolamide in relation to the treatment of glaucoma. (1977) (121)
A quantitative analysis of CO2 transport at rest and during maximal exercise. (1978) (118)
Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. (1993) (114)
Inhibition by anions of human red cell carbonic anhydrase B: physiological and biochemical implications. (1976) (112)
The Development of Topical Carbonic Anhydrase Inhibitors (1995) (104)
The General Physiology of Reactions Catalyzed by Carbonic Anhydrase and Their Inhibition by Sulfonamides a (1984) (100)
The activity of sulfonamides and anions against the carbonic anhydrases of animals, plants, and bacteria. (1983) (99)
A new class of carbonic anhydrase inhibitor. (1993) (90)
The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions. (1982) (87)
Carbonic Anhydrase and the Inner Ear (1961) (83)
The kinetics of HCO3- synthesis related to fluid secretion, pH control, and CO2 elimination. (1988) (80)
Teratogenic action of carbonic anhydrase inhibitors in the rat. (1968) (80)
A kinetic analysis of carbonic anhydrase inhibition. (1960) (76)
The effect of neuro‐ and adenohypophysectomy on retrograde degeneration in hypothalamic nuclei of the rat (1951) (75)
The excretion of drugs across the gill of the dogfish, Squalus acanthias. (1968) (75)
Effects of Acid-Base Alterations on Cerebrospinal Fluid Production (1963) (72)
Bicarbonate formation in cerebrospinal fluid: role in sodium transport and pH regulation. (1972) (71)
Osmotic regulation and urea metabolism in the lemon shark Negaprion brevirostris. (1968) (71)
Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors. (1988) (68)
Carbonic anhydrase inhibition. I. The pharmacology of diamox 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide. (1954) (67)
Sodium, chloride, and bicarbonate movement from plasma to cerebrospinal fluid in cats. (1975) (67)
The rates of movement of Na+, Cl-, and HCO-3 from plasma to posterior chamber: effect of acetazolamide and relation to the treatment of glaucoma. (1976) (63)
The relation between enzyme inhibition and physiological response in the carbonic anhydrase system. (1963) (63)
Carbonic anhydrase inhibition. V. N5-substituted 2-acetylamino-1,3,4-thiadiazole-5-sulfonamides: metabolic conversion and use as control substances. (1956) (63)
Kinetic properties of primitive vertebrate carbonic anhydrases (1980) (63)
Roles of gill and red cell carbonic anhydrase in elasmobranch HCO3- and CO2 excretion. (1987) (62)
The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits. (1983) (62)
Carbonic anhydrase inhibitors: Synthesis and inhibitory properties of 1,3,4-thiadiazole-2,5-bissulfonamide (1996) (61)
Chemistry of the renal reabsorption of bicarbonate. (1974) (60)
Synthesis and physicochemical properties of sulfamate derivatives as topical antiglaucoma agents. (1992) (59)
The role of carbonic anhydrase in anion secretion into cerebrospinal fluid. (1970) (59)
The nature of anion inhibition of human red cell carbonic anhydrases. (1979) (55)
Thermodynamics of carbonic anhydrase catalysis. A comparison between human isoenzymes B and C. (1981) (55)
Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. (1990) (55)
Colorimetric Microdetermination of Antimony with Rhodamine B (1947) (54)
The rates of hydration of carbon dioxide and dehydration of carbonic acid at 37 degrees. (1972) (54)
Effect of acetazolamide on CSF pressure and electrolytes in hydrocephalus (1958) (54)
EFFECTS OF ACID-BASE CHANGES AND CARBONIC ANHYDRASE INHIBITION ON PANCREATIC SECRETION. (1963) (54)
A study of renal carbonic anhydrase. (1967) (53)
The pharmacology of acetazolamide as related to cerebrospinal fluid and the treatment of hydrocephalus. (1960) (52)
Localization and activity of renal carbonic anhydrase (CA) in CA-II deficient mice. (1991) (52)
Membrane carbonic anhydrase (IV) and ciliary epithelium. Carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes. (1996) (51)
Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor. (1997) (51)
Kinetics and inhibition of membrane-bound carbonic anhydrase from canine renal cortex. (1981) (50)
pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. (1993) (50)
CURRENT STATUS OF MEMBRANE‐BOUND CARBONIC ANHYDRASE * (1980) (47)
Acetazolamide treatment of hypokalemic periodic paralysis. Probable mechanism of action. (1975) (47)
Strain differences in susceptibility to the teratogenic effect of acetazolamide in mice. (1973) (46)
Is cyanate a carbonic anhydrase substracte? (1997) (45)
Carbonic anhydrase activity and the distribution of diamox in the rabbit eye. (1955) (44)
SELECTIVE RENAL CARBONIC ANHYDRASE INHIBITION WITHOUT RESPIRATORY EFFECT: PHARMACOLOGY OF 2-BENZENESULFONAMIDO-1,3, 4-THIADIAZOLE-5-SULFONAMIDE (CL 11,366). (1964) (43)
The binding of aromatic sulfonamides to erythrocytes. (1961) (42)
The isolation and partial characterization of sulfonamide-resistant carbonic anhydrases from the liver of the male rat. (1974) (42)
Renal and cerebrospinal fluid formation pharmacology of a high molecular weight carbonic anhydrase inhibitor. (1997) (41)
Effect of AlCl3 and other acids on cerebrospinal fluid production: a correction. (1987) (40)
A comparative study of the kinetics of the Bohr effect in vertebrates. (1980) (40)
Inhibition of Dihydropteroate Synthetase from Escherichia coli by Sulfones and Sulfonamides (1973) (39)
Synthesis and physicochemical properties of thiadiazolo[3,2-a]pyrimidinesulfonamides and thiadiazolo[3,2-a]triazinesulfonamides as candidates for topically effective carbonic anhydrase inhibitors. (1987) (38)
Ionic composition of cerebrospinal fluid and aqueous humor of the dogfish, Squalus acanthias--II. Carbonic anhydrase activity and inhibition. (1962) (36)
Relations among IOP reduction, ocular disposition and pharmacology of the carbonic anhydrase inhibitor ethoxzolamide. (1992) (35)
Pharmacological and renal effects of diamox (6063), a new carbonic anhydrase inhibitor. (1952) (35)
Dihydropteroate synthetase from Plasmodium berghei: isolation, properties, and inhibition by dapsone and sulfadiazine. (1974) (35)
The effect of acetazolamide on the movements of anions into the posterior chamber of the dog eye. (1976) (33)
A study of hepatic carbonic anhydrase. (1966) (32)
Direct measurements of the rate constants of sulfonamides with carbonic anhydrase. (1992) (32)
Ocular pharmacology of methazolamide analogs: distribution in the eye and effects on pressure after topical application. (1987) (32)
The nonenzymatic displacement of the sulfamoyl group from different classes of aromatic compounds by glutathione and cysteine. (1984) (32)
The pharmacology of MS 222 (ethyl-m-aminobenzoate) in Squalus acanthias. (1974) (32)
Renal acid-base physiology in marine teleost, the long-horned sculpin (Myoxocephalus octodecimspinosus). (1992) (31)
The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics. (1984) (31)
Effect of varying CO2 equilibria on rates of HCO3- formation in cerebrospinal fluid. (1979) (30)
Ionic composition of cerebrospinal fluid and aqueous humor of the dogfish, Squalus acanthias--I. Normal values. (1962) (29)
Renal Carbonic Anhydrase and the Pharmacology of Sulfonamide Inhibitors (1969) (29)
Carbonic anhydrase activity of brush border and plasma membranes prepared from rat kidney cortex. (1979) (27)
Ocular pharmacology of sulfonamides: the cornea as barrier and depot. (1985) (27)
The fate of p,p'-DDT (2,2-bis(p-chlorophenyl)-1,1,1-trichloroethane) in the dogfish, Squalus acathias. (1972) (26)
Carbonic Anhydrase: Pharmacology of Inhibitors and Treatment of Glaucoma (1984) (26)
Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151. (1986) (26)
CARBONIC ANHYDRASE KINETICS AND INHIBITION AT 37°: AN APPROACH TO REACTION RATES IN VIVO (1963) (25)
Dissociation of CO2 hydration and renal acid secretion in the dogfish, Squalus acanthias. (1986) (25)
Carbonic anhydrase inhibition. III. Effects of diamox on electrolyte metabolism. (1954) (25)
Ion secretion into the posterior aqueous humor of dogs and monkeys. (1977) (24)
The in vitro activity of sulfonamides against red cell carbonic anhydrases. Effect of ionic and substrate variation on the hydration reaction. (1968) (24)
A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. (1993) (24)
Carbonic anhydrase inhibition. VII. Carbonic anhydrase inhibition and anticonvulsant effect. (1957) (24)
Respiration during chronic inhibition of renal carbonic anhydrase: further observations on pharmacology of 2-benzenesulfonamido-1,3, 4-thiadiazole-5-sulfonamide (CL 11,366), acetazolamide and methazolamide. (1966) (23)
Effects of drugs and physiologic alterations on nasal saltexcretion in sea gulls. (1960) (23)
Kinetics of carbonic anhydrase in whole red cells as measured by transfer of carbon dioxide and ammonia. (1970) (23)
Effects of acidosis and carbonic anhydrase inhibition in the elasmobranch rectal gland. (1984) (23)
Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth. (1967) (23)
The effect of acidosis in hypokalemic periodic paralysis. (1976) (22)
The relation between carbonic anhydrase activity and ion transport in elasmobranch and rabbit lens. (1981) (22)
The binding of inhibitors to carbonic anhydrase in vivo: drugs as markers for enzyme. (1961) (22)
The relations between ionic and non-ionic diffusion of sulfonamides across the rabbit cornea. (1986) (22)
THE ALKALINE (MARSHALL'S) GLAND OF THE SKATE. (1963) (22)
Role of active transport of chloride in formation of dogfish cerebrospinal fluid. (1960) (21)
Kinetics, equilibrium and inhibition in the Hansson histochemical procedure for carbonic anhydrase: A validation of the method (1980) (21)
The rates of ion movement from plasma to aqueous humor in the dogfish, Squalus acanthias. (1975) (19)
The microchemical detection of carbonic anhydrase in corneal epithelia. (1992) (19)
Renal sulfate secretion is carbonic anhydrase dependent in a marine teleost, Pleuronectes americanus. (1999) (19)
The effect of carbonic anhydrase inhibition on intraocular pressure of rabbits with different blood Co2 equilibria. (1960) (18)
Synthesis and Properties of Two New Membrane-Impermeant High-Molecular-Weight Carbonic Anhydrase Inhibitors (1996) (18)
Functional correlates of the dogfish rectal gland during in vitro perfusion. (1975) (17)
Blood levels and excretion rates of antimony in persons receiving trivalent and pentavalent antimonials. (1947) (16)
The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV. (1995) (16)
Carbonic anhydrase inhibition. II. A method for determination of carbonic anhydrase inhibitors, particularly of diamox. (1954) (16)
Carbonic anhydrase inhibition in ophthalmology: aqueous humor secretion and the development of sulfonamide inhibitors. (2000) (16)
Filaricidal Activity of Substituted Phenyl Arsenoxides. (1947) (15)
Teratology and carbonic anhydrase inhibition. (1971) (15)
The carbon dioxide hydration activity of purified teleost red cell carbonic anhydrase. Inhibition by sulfonamides and anions (1982) (15)
Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor. (1995) (14)
Editorials on Recent Advances: HCO3-1 Formation in Aqueous Humor: Mechanisms and relation to the treatment of glaucoma (1974) (14)
The determination of osteopetrotic phenotypes by selective inactivation of red cell carbonic anhydrase isoenzymes. (1985) (14)
The effects of acetazolamide and amiloride on tissue electrolytes, with reference to the teratogenesis of carbonic anhydrase inhibition. (1972) (14)
Absence of carbonic anhydrase in red cell membranes. (1972) (13)
[Topical carbonic anhydrase inhibitors in the treatment of glaucoma]. (1996) (13)
Acute salicylate poisoning. (1972) (13)
RENAL ACTIVITY AND PHARMACOLOGY OF N-ACYL AND RELATED SULFONAMIDES. (1964) (13)
Effects of acetazolamide and metabolic acidosis and alkalosis upon gastric acid secretion. (1962) (13)
Does DDT Inhibit Carbonic Anhydrase? (1971) (13)
Physiological and immunocytochemical evidence for a putative H-K-ATPase in elasmobranch renal acid secretion. (1994) (12)
Rates of Ion Movement from Plasma to Endolymph in the Dogfish (1975) (12)
Carbonic Anhydrase: The Middle Years, 1945–1960, and Introduction to Pharmacology of Sulfonamides (1984) (12)
Carbonic anhydrase inhibition. IV. The effects of metabolic acidosis on the response to diamox. (1956) (12)
Studies on the chemotherapy of filariasis. (1950) (11)
Carbon dioxide equilibria in the kidney: the problems of elevated carbon dioxide tension, delayed dehydration, and disequilibrium pH. (1978) (11)
Acetazolamide and potassium flux in red blood cells. Studies in patients with hyperkalemic periodic paralysis. (1974) (10)
Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates. (1993) (10)
USE OF ARSENICALS IN FILARIASIS (1948) (9)
Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit. (1999) (9)
Forelimb deformity in rats: association with acetazolamide. (1965) (9)
A search for the function of human carbonic anhydrase B. (1978) (9)
The effect of acetazolamide on the movement of sodium into the posterior chamber of the dog eye. (1976) (9)
Formation and Ionic Composition of Cerebrospinal Fluid: The Role of Carbonic Anhydrase (1980) (9)
Studies on the Chemotherapy of Filariasis. Part VI. Studies on the Excretion and Concentration of Antimony in Blood and other Tissues following the Injection of Trivalent and Pentavalent Antimonials into Experimental Animals. (1950) (8)
Carbonic anhydrase in the animal kingdom. (1967) (8)
Carbonic anhydrase inhibition. IX. Augmentation of the renal effect of meralluride by acetazolamide. (1958) (8)
Measurement of aqueous humor flow following scleral injection of sulfacetamide as marker: effect of methazolamide, timolol, and pilocarpine. (1989) (8)
Distribution, metabolism, elimination and toxicity of 14-C-DDT in the dogfish, Squalus acanthias. (1974) (8)
CO2 retention as a basis for increased toxicity of salicylate with acetazolamide: avoidance of increased toxicity with benzolamide. (1975) (8)
The dissociation between renal HCO3 — Reabsorption and H+ secretion in the skate,Raja erinacea (1974) (8)
Physiology and chemistry of cerebrospinal fluid, aqueous humor and endolymph in Squalus acanthias. (1977) (7)
Ion secretion into cerebrospinal fluid. (1977) (7)
Role of Carbonic Anhydrase in Aqueous Humour and Cerebrospinal Fluid Formation (1992) (7)
Aluminum and gallium arrest formation of cerebrospinal fluid by the mechanism of OH- depletion. (1985) (7)
Renal action of acetazolamide in extracellular alkalosis of K deficiency. (1961) (6)
Preparation of a Filaricide. p-[bis-(Carboxy-methylmercapto)-arsino]-benzamide1 (1946) (6)
The pharmacology of the antimalarial drug 4,4'-diformamidodiphenylsulfone (DFD) in dog and monkey. (1972) (6)
Effect of neurohypophysectomy on antidiuretic activity of substituted 3-hydroxy cinchoninic acids in the rat. (1950) (6)
Timolol decreases aqueous humor flow but not Na+ movement from plasma to aqueous. (1997) (6)
Stimulation of the anterior pituitary by certain cinchoninic acid derivatives. (1950) (6)
The pharmacology of trichlormethiazide, a benzothiadiazine diuretic. (1963) (5)
Observations on the rates of ion movement and hypercapnia in aqueous humor. (1973) (5)
The effect of potassium metabolism on acetazolamide-induced teratogenesis. (1972) (5)
Pharmacology of acetazolamide in man, with particular reference to the cerebrospinal fluid (1959) (5)
An estimation of the antipyretic activity of cinchoninic acid derivatives. (1951) (4)
Sulfonamides and secretion of aqueous humor. (1997) (4)
Kinetics of complex formation between human carbonic anhydrase B and heterocyclic sulfonamides. (1974) (4)
Pharmacology: its nature in medicine. (1968) (4)
The effects of metabolic alterations on teratogenesis. (1972) (4)
Volume changes of cerebrospinal fluid in Squalus acanthias during carbonic anhydrase inhibition. (1973) (4)
Kinetics and inhibition of carbonic anhydrase-catalyzed hydrolysis of 2-hydroxy-5-nitro-alpha-toluenesulfonic acid sultone. Comparison with reactions of other substrates. (1983) (4)
Acetazolamide and advanced liver disease. (1986) (4)
The pharmacology of ethyl m-aminobenzoate (MS 222) in the dogfish, Squalus acanthias (1967) (4)
The teratological effect of certain thiadiazoles related to acetazolamide, with a note on sulfanilamide and thiazide diuretics. (1972) (4)
THE KINETICS OF CARBONIC ANHYDRASE AND ITS INHIBITION IN VIVO (1965) (4)
Enhancement of the ocular hypotensive effect of acetazolamide by diflunisal. (1988) (4)
Studies in the Pharmacology of Mercury. II. Distribution of Mercury in Mice Following Administration of Hydrophilic Mercury and Calomel Ointments (1944) (3)
To what extent does acetazolamide inhibit renal bicarbonate reabsorption? (1979) (3)
Diuretics and Renal Drug Development (1987) (3)
Pharmacology of Nicotine (1951) (3)
The ocular distribution of methazolamide after corneal and scleral administration: the effect of ionization state. (1998) (3)
Effects of carbonic anhydrase inhibitors on potassium exchange in human red blood cells. (1974) (3)
Ocular hypotensive activity and disposition of the topical carbonic anhydrase inhibitor 6-hydroxy-benzo[b]thiophene-2-sulfonamide, L-650,719, in the rabbit. (1989) (3)
Thermodynamics of Carbonic Anhydrase Catalysis (2001) (3)
The relation between renal acidification and bicarbonate reabsorption. A view of CO2-mediated secretion in renal and other epithelia (1973) (3)
Importance of Carbonic Anhydrase in the Production of Cerebrospinal Fluid (1984) (3)
Determination of arylamines in urine without the interference of indican. (1971) (3)
Report of the subcommittee on position and status of the clinical pharmacologist in drug research (1964) (3)
THE PHARMACOLOGY OF THE ANTIMALARIAL DRUG 4,4'-DIFORMAMIDODIPHENYLSULFONE (DFD) IN MAN (1972) (3)
Lack of Effect of Carbonic Anhydrase Inhibition on Direct Measurements of Endolymph Bicarbonate (1989) (2)
Principles of Drug Action. The Basis of Pharmacology. Avram Goldstein, Lewis Aronow, and Sumner M. Kalman. Harper and Row, New York, 1968. xii + 884 pp., illus. $18.50 (1969) (2)
The microdetermination of antimony. (1945) (2)
Acetazolamide does not disrupt limb regenerate morphogenesis in the salamander, Plethodon cinereus. (1986) (2)
The permeability of hydrophobic membranes to 22Na salts and 14CO2 in low dielectric media. (1989) (2)
Treatment of canine filariasis with trivalent arsenicals (p-arsenosobenzamides). (1945) (2)
Corneal sequestration and delivery to ciliary process of six topically applied sulfonamides. (1999) (2)
STUDIES ON THE CHEMOTHERAPY OF FILARIASISPARTS I–IV (1949) (2)
4,4'-diformamidodiphenylsulfone (DFD): analysis of plasma and urine for unsubstituted arylamine in the presence of metabolites and acid-labile substituents on the parent compound. (1972) (2)
Hepatic carbonic anhydrase inhibition by diuretic drugs (1987) (2)
The fate of two arsenoxides in the dog. (1949) (1)
Ivermectin in lymphatic filariasis. (1990) (1)
Carbonic anhydrase inhibition. VIII. Lack of renal response to acetazolamide and to meralluride in a dog with chronic nephritis. (1958) (1)
Carbonic anhydrase. (1985) (1)
Subject Index, Vol. 9, 1986 (1986) (1)
Studies on the chemotherapy of filariasis. (1949) (1)
The teratological effect of benzolamide, a new carbonic anhydrase inhibitor. (1972) (1)
Failure of renal response to acetazolamide and to meralluride in a dog with chronic nephritis (1957) (1)
Effect of carbonic anhydrase inhibition on (U-B)pCO2 in the alkaline urine of the rabbit. (1986) (1)
Renal sulfate secretion is carbonic anhydrase dependent in a marine teleost, Pleuronectes americanus. (1999) (1)
Studies on the Chemotherapy of Filariasis. Part V. Studies on the Pharmacology of Arsenamide and related Arsenicals. (1950) (1)
The Effect of Acetazolamide on the Transport of Potassium and Rubidium into Guinea Pig Diaphragm 1 (1974) (1)
DIURESIS from carbonic anhydrase inhibition. (1955) (1)
Great expectations. (1982) (1)
The distribution, excretion, and blood levels of antimony following administration of antimonials to various mammalian species. (1948) (1)
Carbonic anhydrase kinetics and inhibition at 37 degrees: an approach to reaction rates in vivo. (1963) (1)
Eli Kennerly Marshall: May 2, 1889-January 10, 1966. (1986) (0)
Pharmacology: its nature in a medical school. (1963) (0)
Synthesis and Physicochemical Properties of Thiadiazolo(3,2-a)pyrimidinesulfonamides and Thiadiazolo(3,2-a)triazinesulfonamides as Candidates for Topically Effective Carbonic Anhydrase Inhibitors. (1988) (0)
Carbonic Anhydrase Inhibitors: Synthesis and Inhibitory Properties of 1,3,4-Thiadiazole-2,5-bissulfonamide. (1997) (0)
Contents, Vol. 9, 1986 (1986) (0)
Role of pharmacology in physician education. (1973) (0)
Acute salicylate poisoning. (1972) (0)
Forelimb Deformity in Rats: Association with Acetazolamide (1965) (0)
Sulfate secretion by flounder renal epithelium is carbonic anhydrase dependent (1997) (0)
Lasker Award and opiate receptors. (1979) (0)
Inhibition by anions of human red cell carbonic anhydrase B: physiological and biochemical implications. (1976) (0)
The Fundamental Concepts of Pharmacology: Principles of Drug Action . The Basis of Pharmacology. Avram Goldstein, Lewis Aronow, and Sumner M. Kalman. Harper and Row, New York, 1968. xii + 884 pp., illus. $18.50. (1969) (0)
Diuretics found effective against meningococci? (1967) (0)
Physiological Consequences of Carbonic Anhydrase Inhibition During Rest and Exercise, and on the Bohr Effect (1980) (0)
Mechanisms of anion inhibition of human red cell carbonic anhydrases (1979) (0)
Introductory Remarks (1984) (0)
Studies in the pharmacology of mercury. IV. In vitro activity of mercury dispersion against Neisseria gonorrhoeae (1944) (0)
Errors in measurement of the activity of carbonic anhydrase inhibitors. (1988) (0)
Comparative filaricidal activity of trivalent arsenic and antimony. (1947) (0)
Possible use of an arsenical compound in the treatment of heartworm in dogs. (1947) (0)
Studies on the Chemotherapy of Filariasis. Part VII. Comparative Review of the Possible Therapeutic Agents available for Canine and Human Filariasis. (1950) (0)
Inhibition ofDihydropteroate Synthetase from Escherichia coli bySulfones andSulfonamides (1973) (0)
Studies in the pharmacology of mercury. I. Water‐soluble dispersion of mercury (1943) (0)
Acute salicylate poisoning. (1972) (0)
Sulfonamides in Treatment of Meningococcal Meningitis (1964) (0)
As the twig is bent... (1982) (0)
COLONIC LOSS OF POTASSIUM (1964) (0)
Carbonic anhydrase and respiratory distress. (1968) (0)
87 Discussion of previous paper (1961) (0)
Recovery from metabolic acidosis is a function of renal NH+4 loss: agreement between two models. (1987) (0)

This paper list is powered by the following services:

Other Resources About Thomas H. Maren

en.wikipedia.org

What Schools Are Affiliated With Thomas H. Maren?

Thomas H. Maren is affiliated with the following schools:

Thomas H. Maren's Academic­Influence.com Rankings

Thomas H. Maren's Degrees

Why Is Thomas H. Maren Influential?

Thomas H. Maren's Published Works

Published Works

Other Resources About Thomas H. Maren

What Schools Are Affiliated With Thomas H. Maren?

Thomas H. Maren's AcademicInfluence.com Rankings